| First malaria vaccine; targets the pre-erythrocytic stage of P. falciparum |
| Shows vaccine efficacy against P. falciparum malaria in children; can be used to prevent seasonal malaria |
| Acceptable safety and tolerability profile |
| Recommended by WHO; cost effective; provides equitable access to malaria prevention; can be incorporated in routine national immunization programmes |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.